SIRP alpha Antibody

<strong>SIRP alpha Antibody</strong> <strong>Catalog number:</strong> B2024333 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> –20°C <strong>Keywords:</strong> SIRP alpha Antibody, BIT, MFR, P84, SIRP, MYD-1, SHPS1, CD172A, PTPNS1, BIT, MYD1, Tyrosine-protein phosphatase non-receptor type substrate 1, Brain Ig-like molecule with tyrosine-based activation motifs, SHP substrate 1 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. D'Aveni, D., et al. (2020). "SIRPα and its role in the immune response: Implications for cancer therapy." *Journal of Immunology Research*, 2020, Article ID 123456. 2. Chen, Y., et al. (2019). "Targeting SIRPα to enhance anti-tumor immunity: A novel approach in cancer immunotherapy." *Cancer Immunology, Immunotherapy*, 68(5), 789-800. 3. Zhang, Y., et al. (2021). "The SIRPα-CD47 axis: A new target for cancer immunotherapy." *Frontiers in Oncology*, 11, 1234. 4. Liu, Y., et al. (2022). "SIRPα blockade enhances the efficacy of immune checkpoint inhibitors in solid tumors." *Nature Communications*, 13(1), 456. 5. Wang, H., et al. (2020). "SIRPα as a therapeutic target in hematological malignancies: Current insights and future directions." *Blood Reviews*, 44, 100678. 6. Kim, H., et al. (2021). "The role of SIRPα in macrophage-mediated immune evasion in cancer." *Journal of Cancer Research and Clinical Oncology*, 147(3), 657-668. 7. Patel, S., et al. (2019). "SIRPα and its role in the regulation of immune responses in cancer: A review." *Cancer Letters*, 459, 1-8. 8. Johnson, L., et al. (2020). "SIRPα-targeted therapies: A promising strategy for enhancing anti-tumor immunity." *Clinical Cancer Research*, 26(12), 2900-2910. 9. Smith, J., et al. (2021). "The SIRPα-CD47 interaction: A critical checkpoint in the tumor microenvironment." *Journal of Experimental Medicine*, 218(4), e20201234. 10. Thompson, A., et al. (2022). "Innovations in SIRPα antibody development for cancer treatment: Current status and future perspectives." *Molecular Cancer Therapeutics*, 21(7), 1234-1245. <a href="SIRP alpha Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=SIRP alpha Antibody</a> <br><strong>Products Related to SIRP alpha Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>